Page last updated: 2024-08-25

dimethylarsine and Leukemia, Promyelocytic, Acute

dimethylarsine has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

*Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gao, C; Hai, X; Li, J; Lin, L; Lv, J; Tian, S; Wu, M1

Other Studies

1 other study(ies) available for dimethylarsine and Leukemia, Promyelocytic, Acute

ArticleYear
Monomethylarsonous acid binds to Cys-104α and Cys-112β of hemoglobin in acute promyelocytic leukemia patients treated with arsenic trioxide.
    Toxicology letters, 2023, May-01, Volume: 380

    Topics: Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Hemoglobins; Humans; Leukemia, Promyelocytic, Acute; Oxides

2023